KR830010103A - 카르복시미드 유도체 및 그것을 함유하는 의약의 제조방법 - Google Patents
카르복시미드 유도체 및 그것을 함유하는 의약의 제조방법 Download PDFInfo
- Publication number
- KR830010103A KR830010103A KR1019820002402A KR820002402A KR830010103A KR 830010103 A KR830010103 A KR 830010103A KR 1019820002402 A KR1019820002402 A KR 1019820002402A KR 820002402 A KR820002402 A KR 820002402A KR 830010103 A KR830010103 A KR 830010103A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- structural formula
- pyridyl
- salt
- piperazin
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 4
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical class C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims 17
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 13
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 11
- 125000004076 pyridyl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims 7
- 239000003937 drug carrier Substances 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 206010012601 diabetes mellitus Diseases 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 4
- -1 aralkenyl group Chemical group 0.000 claims 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- WLDMPODMCFGWAA-OLQVQODUSA-N (3as,7ar)-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione Chemical compound C1CCC[C@@H]2C(=O)NC(=O)[C@@H]21 WLDMPODMCFGWAA-OLQVQODUSA-N 0.000 claims 1
- QGRNPXJYRHOPIJ-UHFFFAOYSA-N 2-[2-(pyridin-3-ylmethoxy)-3-(4-pyridin-2-ylpiperazin-1-yl)propyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(OCC=1C=NC=CC=1)CN(CC1)CCN1C1=CC=CC=N1 QGRNPXJYRHOPIJ-UHFFFAOYSA-N 0.000 claims 1
- HBVWFAPMUBIIIJ-UHFFFAOYSA-N [1-(1,3-dioxoisoindol-2-yl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-yl] propanoate Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(OC(=O)CC)CN(CC1)CCN1C1=CC=CC=N1 HBVWFAPMUBIIIJ-UHFFFAOYSA-N 0.000 claims 1
- RZXAVWJBTZHCHQ-UHFFFAOYSA-N [1-(2,5-dioxopyrrolidin-1-yl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-yl] cyclohexanecarboxylate Chemical compound C1CCCCC1C(=O)OC(CN1CCN(CC1)C=1N=CC=CC=1)CN1C(=O)CCC1=O RZXAVWJBTZHCHQ-UHFFFAOYSA-N 0.000 claims 1
- ACZIFYHXUYZRME-UHFFFAOYSA-N [1-(2,5-dioxopyrrolidin-1-yl)-3-(4-pyridin-2-ylpiperazin-1-yl)propan-2-yl] octanoate Chemical compound C1CN(C=2N=CC=CC=2)CCN1CC(OC(=O)CCCCCCC)CN1C(=O)CCC1=O ACZIFYHXUYZRME-UHFFFAOYSA-N 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 235000019988 mead Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
- C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 다음 구조식(Ⅱ) 화합물을 다음 구조식(Ⅲ) 화합물과 반응시켜 다음 구조식(I)의 카르복시미드 유도체 또는 이것의 약학적으로 혀용될 수 있는 염의 제조방법.상기 구조식에서X는 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 또는 구조식의 그룹 : Y는 알킬그룹, 아르알킬그룹, 아릴그룹, 치환되거나 또는 치환되지 않는 피리딜그룹, 치환되거나 또는 치환되지 않은 피리딜 그룹 또는 벤조티아졸릴 그룹이고 m은 2 또는 3의 정수를 나타낸다.
- 다음 구조식(Ⅰ)의 화합물을 다음 구조식(Ⅴ)의 카르복실산 또는 이것의 반응성 유도체와 반응시켜 다음 구조식(Ⅳ)의 카르복시시미드 유도체 또는 이것의 약학적으로 허용될 수 있는 염의 제조방법.RCOOH (Ⅴ)상기 구조식에서,X는 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹 또는 구조식의 그룹이고 : Y는 알킬그룹, 아르알킬그룹, 아릴그룹, 치환되거나 또는 치환되지 않은 피리딜그룹, 치환되거나 또는 치환되지 않은 피리미딜그룹 또는 벤조티아졸릴 그룹 : R는 아킬그룹, 아르알킬그룹, 아릴그룹, 시클로알킬그룹, 알케닐그룹, 아르알케닐그룹 또는 피리딜그룹 : 이고 m은 2 또는 3의 정수를 나타낸다.
- 다음 구조식(Ⅰ) 화합물을 다음 구조식(Ⅵ) 화합물과 반응시켜 다음 구조식(Ⅳ)의 카르복시이미드 유도체 또는 이것의 약학적으로 받아들여질 수 있는 염을 제조하는 방법.R1NCO (Ⅵ)상기 구조식에서X는 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹 또는 구조식의 그룹 : Y는 알킬그룹, 아르알킬그룹, 아릴그룹, 치환되거나 또는 치환되지 않는 피리딜그룹, 또는 벤조티아졸일그룹 : R은 치환된 아미노그룹이고, m은 2 또는 3의 정수를 나타낸다.
- 활성성분으로서 다음 구조식(Ⅶ)의 카르복시미드 유도체 또는 약학적으로 허용될 수 있는 염과 약학적으로 허용될 수 있는 담체로 구성되는 당뇨병치료를 위한 약학적 조성물.상기 구조식에서X는 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 구조식의 그룹, 또는 Z는 수소원자 또는 구조식의 그룹, (여기서 R은 알킬그룹, 아르알킬그룹, 아릴그룹, 시클로알킬그룹, 알케닐그룹, 아르알케닐그룹, 피리딜그룹 또는 치환된 아미노그룹), Y는 알킬그룹, 아르알킬그룹, 아릴그룹, 치환되거나 또는 치환되지 않은 피리딜그룹, 치환되거나 또는 치환되지 않은 피리미딜 그룹 또는 벤조티아졸릴그룹 : 이고 m은 2 또는 3의 정수를 나타낸다.
- 제4항에 있어서, 활성성분으로서 카르복시미드 유도체 또는 구조식(Ⅶ)에서 Y가 치환되거나 또는 치환되지 않은 피리딜 그룹인 약학적으로 허용될 수 있는 염과 약학적으로 허용할 수 있는 담체로 구성되는 당노병 치료를 위한 약학적 조성물.
- 제4항에 있어서, 활성성분으로서 카리복시미드 유도체 또는 구조식(Ⅶ)에서 Y가 2-피르딜그룹인 약학적으로 허용될 수 있는 염과 약학적으로 허용될 수 있는 담체로 구성되는 당뇨병 치료를 위한 약학적 조성물.
- 제4항에 있어서, 활성성분으로서 또는 구조식(Ⅶ)에서 X가 구조식이고 Y가 2-피리딜인 카르복시미드 유도체 이것의 약학적으로 허용될 수 있는 염과 약학적으로 허용될 수 있는 담체로 구성되는 당뇨병 치료를 위한 조성물.
- 제4항에 있어서 활성성분으로서 카르복시이미드 또는 구조식(Ⅶ)에서 X기 구조식이고 Y가 2-피리딜이며 Z가 구조식(여기서 R은 알킬그룹, 아르알킬그룹, 아릴그룹, 시클로알킬그룹, 알케닐그룹, 아르알케닐그룹, 피리딜그룹 또는 치환된 아미노그룹, 약학적으로 허용될 수 있는 염과 약학적으로 허용될 수 있는 담체로 구성되는 당뇨병 치료를 위한 약학적 조성물.
- 제4항에 있어서 활성성분으로서 카르복시미드 유도체의 어느 하나 또는 다음 그룹의 염으로부터 선택된 약학적으로 허용될 수 있는 염과 약학적으로 허용될수 있는 담체로 구성되는 당뇨병 치료를 위한 약학적 조성물 :N-[2-시클로헥실카르보닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 엔도-시스-비스클로[2,2,1] 햅트-5-엔-2,3-디카르복시미드의 염.N-[2-n-카프로일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-프로피오닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 프탈리미드의 염.N-[2-니코티닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 프탈리미드의 염.N-[2-(트란스-2-노네노일옥시)-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-팔미토일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-시클로헥실카르보닐옥시-3-{4-(2-피리딜) 피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-n-카프로일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 프탈리미드의 염.N-[2-n-옥타노일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 석씨니미드의 염.N-[2-시클로헥실카르보닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 석씨니미드의 염.N-[2-n-데카노일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-니코티닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-이소부티릴옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1,2-디카르복시미드의 염.N-[2-옥타노일옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥스-4-엔-1, 2-디카르복시미드의 염.N-[2-시클로헥실카르보닐옥시-3-{4-(2-피리딜)피페라진-1-일}프로필] 시스-시클로헥산-1, 2-디카르복시미드의 염.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870003834A KR880000450B1 (ko) | 1981-05-29 | 1987-04-20 | 카르복시이미드 유도체의 제조방법 |
KR1019870003835A KR880000451B1 (ko) | 1981-05-29 | 1987-04-20 | 카르복시이미드 유도체의 제조방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56080866A JPS57197265A (en) | 1981-05-29 | 1981-05-29 | Carboxylic acid imide derivative, its preparation and medicament containing the same |
JP80866 | 1981-05-29 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870003834A Division KR880000450B1 (ko) | 1981-05-29 | 1987-04-20 | 카르복시이미드 유도체의 제조방법 |
KR1019870003835A Division KR880000451B1 (ko) | 1981-05-29 | 1987-04-20 | 카르복시이미드 유도체의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830010103A true KR830010103A (ko) | 1983-12-26 |
KR870001027B1 KR870001027B1 (ko) | 1987-05-25 |
Family
ID=13730258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR8202402A KR870001027B1 (ko) | 1981-05-29 | 1982-05-29 | 카르복시이미드 유도체의 제조방법 |
Country Status (15)
Country | Link |
---|---|
US (1) | US4479954A (ko) |
JP (1) | JPS57197265A (ko) |
KR (1) | KR870001027B1 (ko) |
BE (1) | BE893378A (ko) |
CA (1) | CA1211436A (ko) |
CH (1) | CH649287A5 (ko) |
DE (1) | DE3220262A1 (ko) |
DK (1) | DK241982A (ko) |
ES (3) | ES8308548A1 (ko) |
FR (1) | FR2506771A1 (ko) |
GB (1) | GB2101590B (ko) |
IT (1) | IT1151781B (ko) |
NL (1) | NL8202173A (ko) |
PH (3) | PH19837A (ko) |
SE (1) | SE450894B (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507303A (en) * | 1981-12-22 | 1985-03-26 | Sumitomo Chemical Company, Limited | Succinimide derivatives, compositions and method of use |
US4641251A (en) * | 1982-02-16 | 1987-02-03 | Inoue-Japax Research Incorporated | Robot |
JPS5976059A (ja) * | 1982-10-21 | 1984-04-28 | Sumitomo Chem Co Ltd | 環状イミド誘導体及びその酸付加塩 |
JPS5995267A (ja) * | 1982-11-25 | 1984-06-01 | Eisai Co Ltd | カルボン酸イミド誘導体およびその製造方法 |
DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
US4562255A (en) * | 1984-03-30 | 1985-12-31 | American Home Products Corporation | Substituted bi-alicyclic imides |
JPH0625181B2 (ja) * | 1985-03-27 | 1994-04-06 | 住友製薬株式会社 | 新規なイミド誘導体 |
JPS61238784A (ja) * | 1985-04-17 | 1986-10-24 | Sumitomo Seiyaku Kk | コハク酸イミド誘導体及びその酸付加塩 |
JP2660407B2 (ja) * | 1986-09-26 | 1997-10-08 | 住友製薬株式会社 | 新規なイミド誘導体 |
DE8630918U1 (ko) * | 1986-11-18 | 1987-11-05 | Fritz Bauer + Soehne Ohg, 8503 Altdorf, De | |
US4804751A (en) * | 1987-06-30 | 1989-02-14 | American Home Products Corporation | Polycyclic hydrocarbon succinimides with psychotropic activity |
US5053508A (en) * | 1990-03-09 | 1991-10-01 | American Home Products Corporation | Fused heterotricyclic imides with psychotropic activity and intermedrates thereof |
US6083950A (en) * | 1997-11-13 | 2000-07-04 | Ranbaxy Laboratories Limited | 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers |
WO2000005206A1 (en) * | 1998-07-21 | 2000-02-03 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers |
SK932001A3 (en) * | 1998-07-21 | 2001-08-06 | Ranbaxy Lab Ltd | ARYLPIPERAZINE DERIVATIVES USEFUL AS UROSELECTIVEì (54) ALPHA1-ADRENOCEPTOR BLOCKERS |
WO2002044151A1 (en) | 2000-11-30 | 2002-06-06 | Ranbaxy Laboratories Limited | 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers |
EP1495000A4 (en) * | 2002-04-08 | 2005-10-05 | Ranbaxy Lab Ltd | ALPHA, OMEGA DICARBOXIMID DERIVATIVES SUITED AS UROSELECTIVE A1A ADRENEOCEPTOR BLOCKERS |
ES2378990T3 (es) | 2003-07-29 | 2012-04-19 | Dainippon Sumitomo Pharma Co., Ltd. | Procedimiento para producir un compuesto imida |
EP1758583A2 (en) * | 2004-05-31 | 2007-03-07 | Ranbaxy Laboratories Limited | Arylpiperazine derivatives useful as adrenergic receptor antagonists |
US20060247249A1 (en) * | 2005-11-16 | 2006-11-02 | Mohammad Salman | Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126396A (en) * | 1964-03-24 | Chiih | ||
US3126395A (en) * | 1964-03-24 | Chj czhs | ||
US2343198A (en) * | 1940-04-03 | 1944-02-29 | Abbott Lab | Nu-alkamine substituted derivatives of phthalimide |
US3198798A (en) * | 1962-11-02 | 1965-08-03 | Sterling Drug Inc | Phthalimido- and isoindolinyl-alkylpiperazines and their preparation |
US3563986A (en) * | 1965-10-12 | 1971-02-16 | Ernst Frankus | 4 - phthalimido - n - heterocyclic amino methyl or piperidino hydrazino piperidine diones 2,6 |
US3579524A (en) * | 1968-06-05 | 1971-05-18 | Miles Lab | 2-aminoalkyl derivatives of phthalimidines |
US3850921A (en) * | 1972-09-20 | 1974-11-26 | I Matuo | Derivatives of 2,3-norbornanedicarboxamide |
US3936449A (en) * | 1974-04-11 | 1976-02-03 | Sadao Ohki | Anti-arrhythmic agents |
US3980667A (en) * | 1975-03-05 | 1976-09-14 | Bristol-Myers Company | Anti-arrhythmic 5-endo-substituted oxy-N-(aminoloweralkyl)bicycle [2.2.2.]oc |
US4018767A (en) * | 1975-05-22 | 1977-04-19 | Bristol-Myers Company | Anti-arrhythmic agents |
US4070465A (en) * | 1976-06-24 | 1978-01-24 | E. R. Squibb & Sons, Inc. | Various 2-(substituted piperazinyl)-1H-benz [de]isoquinoline-1,3 (2H) -diones |
US4139533A (en) * | 1976-08-19 | 1979-02-13 | Bristol-Myers Company | Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid |
-
1981
- 1981-05-29 JP JP56080866A patent/JPS57197265A/ja active Granted
-
1982
- 1982-05-26 SE SE8203272A patent/SE450894B/sv not_active IP Right Cessation
- 1982-05-27 US US06/382,792 patent/US4479954A/en not_active Expired - Fee Related
- 1982-05-27 NL NL8202173A patent/NL8202173A/nl not_active Application Discontinuation
- 1982-05-28 PH PH27367A patent/PH19837A/en unknown
- 1982-05-28 DE DE19823220262 patent/DE3220262A1/de not_active Withdrawn
- 1982-05-28 CH CH3333/82A patent/CH649287A5/de not_active IP Right Cessation
- 1982-05-28 ES ES512642A patent/ES8308548A1/es not_active Expired
- 1982-05-28 FR FR8209376A patent/FR2506771A1/fr active Granted
- 1982-05-28 DK DK241982A patent/DK241982A/da not_active Application Discontinuation
- 1982-05-28 CA CA000403984A patent/CA1211436A/en not_active Expired
- 1982-05-28 IT IT21563/82A patent/IT1151781B/it active
- 1982-05-29 KR KR8202402A patent/KR870001027B1/ko active
- 1982-06-01 GB GB08215992A patent/GB2101590B/en not_active Expired
- 1982-06-01 BE BE0/208242A patent/BE893378A/fr not_active IP Right Cessation
-
1983
- 1983-06-13 ES ES523205A patent/ES523205A0/es active Granted
-
1984
- 1984-01-09 PH PH30076A patent/PH19291A/en unknown
- 1984-01-09 PH PH30077A patent/PH19272A/en unknown
- 1984-11-16 ES ES537721A patent/ES537721A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
PH19837A (en) | 1986-07-22 |
ES8601156A1 (es) | 1985-10-16 |
GB2101590B (en) | 1985-06-19 |
ES537721A0 (es) | 1985-10-16 |
GB2101590A (en) | 1983-01-19 |
ES8503343A1 (es) | 1985-02-16 |
SE8203272L (sv) | 1982-11-30 |
PH19291A (en) | 1986-03-04 |
JPH0229671B2 (ko) | 1990-07-02 |
JPS57197265A (en) | 1982-12-03 |
DK241982A (da) | 1982-11-30 |
NL8202173A (nl) | 1982-12-16 |
FR2506771A1 (fr) | 1982-12-03 |
KR870001027B1 (ko) | 1987-05-25 |
ES512642A0 (es) | 1983-09-01 |
BE893378A (fr) | 1982-12-01 |
PH19272A (en) | 1986-02-21 |
SE450894B (sv) | 1987-08-10 |
IT1151781B (it) | 1986-12-24 |
ES523205A0 (es) | 1985-02-16 |
US4479954A (en) | 1984-10-30 |
FR2506771B1 (ko) | 1985-03-01 |
CA1211436A (en) | 1986-09-16 |
ES8308548A1 (es) | 1983-09-01 |
IT8221563A0 (it) | 1982-05-28 |
CH649287A5 (de) | 1985-05-15 |
DE3220262A1 (de) | 1982-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830010103A (ko) | 카르복시미드 유도체 및 그것을 함유하는 의약의 제조방법 | |
NO179638C (no) | Analogifremgangsmåte for fremstilling av tiazolderivater | |
NZ238424A (en) | 3,5-substituted indole derivatives; medicaments and preparatory processes. | |
AU6128590A (en) | Novel compounds | |
ATE185807T1 (de) | Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
DE3167757D1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
AU6129890A (en) | Novel compounds | |
KR830009118A (ko) | 세펨화합물의 제조방법 | |
ATE26716T1 (de) | 2-(haloergolinyl)-n'n'-diaethylharnstoff-derivat , verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
GR3031029T3 (en) | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase. | |
KR880006231A (ko) | 이미다졸리디논 화합물 및 그의 제조 방법 | |
IE872658L (en) | Tetrahydroquinoline derivatives, a process for their preparation, their use and pharmaceutical formulations containing them | |
DE3882438T2 (de) | Alkansulfonanilid-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung. | |
AU1901388A (en) | N-((2-oxopyrrolidin-1-yl)acetyl)piperazine derivatives and drug for senile dementia | |
KR840000534A (ko) | 디히드로피리딘 화합물류의 제조방법 | |
FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
KR860009009A (ko) | 옥소티아졸리딘 화합물의 제조방법 | |
TW369528B (en) | Alpha-substituted benzyl heterocyclic derivatives, a process for producing intermediates and containing the same as a fungicide or insecticide active ingredient | |
DE69625795T2 (de) | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten | |
KR910011839A (ko) | 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제 | |
JPS5576872A (en) | Imidazolidinone derivative | |
KR890003779A (ko) | β-락탐 화합물, 이 화합물의 제조방법, 이 화합물의 합성용 중간체 및 이 화합물을 함유하는 세균감염 질환 치료용 의약조성물 | |
WO1987004435A3 (en) | Xanthine compounds | |
HUT45016A (en) | Herbicides containing as active substance derivatives of piridil-phenil-ether and process for production of these derivatives |